Progenity Stock

Progenity Debt 2024

Progenity Debt

38 USD

Ticker

PROG

ISIN

US74319F1075

WKN

A2P7FX

In 2024, Progenity's total debt was 38 USD, a 0% change from the 0 USD total debt recorded in the previous year.

Progenity Aktienanalyse

What does Progenity do?

Progenity Inc. is an American company specializing in the development and marketing of diagnostic tests and genetic screening solutions. It was founded in 2012 and is headquartered in San Diego, California. Progenity is a leading provider of prenatal screening and diagnostic solutions. The company offers a wide range of tests that help expectant parents identify potential health risks for their unborn child. Progenity's prenatal screening palette includes tests for determining chromosomal abnormalities, genetic disorders, and other health risks. A major advantage of these tests is that they are non-invasive, meaning that no dangerous invasive procedures need to be performed. Another important division of Progenity focuses on gastrointestinal health, where the company offers various diagnostic tests to identify and treat gastrointestinal diseases early. This includes tests for detecting colon cancer as well as genetic tests that indicate an increased risk for familial colon cancer syndromes. Progenity also has a division that focuses on cardiovascular diseases. Here, they offer genetic tests, among other things, to determine the risk of heart disease. In addition, the company offers a wide range of diagnostic solutions for general health, such as tests for identifying infectious diseases like HIV or HPV. Progenity also offers its customers various screening and diagnostic tests tailored to specific target groups. This includes tests for women seeking fertility treatment, as well as tests aiming to identify specific hereditary diseases related to cancer or other conditions. To provide customers with the best possible solutions, Progenity utilizes state-of-the-art technologies and innovative methods. The company is a leader in the application of liquid biopsy tests, an innovative method for identifying cancer cells in the blood. For a long time, Progenity has worked closely with leading US health authorities and is accredited by CLIA, the Clinical Laboratory Improvement Amendments. This means that the company operates in accordance with established standards and best practices and can provide its customers with accurate and reliable diagnostic solutions. In recent years, Progenity has experienced an impressive growth rate and has become a recognized provider of diagnostic solutions with a wide range of tests covering various areas of health. The company is committed to providing customers with the best possible solutions to promote their health and well-being. Progenity ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Progenity's Debt Structure

Progenity's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Progenity's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Progenity’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Progenity’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Progenity stock

What is the debt of Progenity this year?

Progenity has a debt level of 38 USD this year.

What was the debt of Progenity compared to the previous year?

The debt of Progenity has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Progenity?

High debt can pose a risk for investors of Progenity, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Progenity?

Low debt means that Progenity has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Progenity affect the company?

An increase in debt of Progenity can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Progenity affect the company?

A reduction in debt of Progenity can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Progenity?

Some factors that can influence the debt of Progenity include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Progenity so important for investors?

The debts of Progenity are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Progenity take to change the debt?

To change the debt, Progenity can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Progenity pay?

Over the past 12 months, Progenity paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Progenity is expected to pay a dividend of 0 USD.

What is the dividend yield of Progenity?

The current dividend yield of Progenity is .

When does Progenity pay dividends?

Progenity pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Progenity?

Progenity paid dividends every year for the past 0 years.

What is the dividend of Progenity?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Progenity located?

Progenity is assigned to the 'Health' sector.

Wann musste ich die Aktien von Progenity kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Progenity from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.

When did Progenity pay the last dividend?

The last dividend was paid out on 12/3/2024.

What was the dividend of Progenity in the year 2023?

In the year 2023, Progenity distributed 0 USD as dividends.

In which currency does Progenity pay out the dividend?

The dividends of Progenity are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Progenity

Our stock analysis for Progenity Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progenity Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.